Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129488 · ClinicalTrials.gov registry record · NA
Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05129488 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 33 participants.
The verdict
NCT05129488, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The objective of this 2 hour study is to evaluate the clinical performance of Biotrue ONEday lenses with an alternate packaging solution (EPG03) compared to commercially available Biotrue ONEday lenses. This novel contact lens packaging solution contains known elements in the ophthalmic industry and is safe for use.
Interventions
- DEVICE All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2021-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05129488
The ClinicalTrials.gov registry entry for NCT05129488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03) is the first listed.
NCT05129488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05129488 about?
NCT05129488 is a clinical study titled "Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses". The objective of this 2 hour study is to evaluate the clinical performance of Biotrue ONEday lenses with an alternate packaging solution (EPG03) compared to commercially available Biotrue ONEday lenses. This novel contact lens packaging solution contains known elements in the ophthalmic industry and...
What is the current status of trial NCT05129488?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-09-15. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT05129488?
The interventions under investigation include: All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03) (DEVICE).
Who is sponsoring clinical trial NCT05129488?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.